Search research articles
Contact Us
Filters
Showing results (721-730 of 774) with videos related to
Page
of 78
Sort By:
Pediatrics
|
February 1, 1997
Improving care for minority children with asthma: professional education in public health clinics
D Evans, R Mellins, K Lobach, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 26, 1994
L-735,524: an orally bioavailable human immunodeficiency virus type 1 protease inhibitor
J P Vacca, B D Dorsey, W A Schleif, et al.
International Journal of Cancer
|
August 26, 1998
Familial aggregation of colorectal cancer in Egypt
A S Soliman, M L Bondy, B Levin, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 15, 1995
Preoperative infusional chemoradiation therapy for stage T3 rectal cancer
T A Rich, J M Skibber, J A Ajani, et al.
Bioorganic & Medicinal Chemistry
|
September 1, 1994
Synthesis, antiviral activity, and bioavailability studies of gamma-lactam derived HIV protease inhibitors
R W Hungate, J L Chen, K E Starbuck, et al.
CA: a Cancer Journal for Clinicians
|
October 2, 2001
American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. Also: update 2001--testing for early lung cancer detection
R A Smith, A C von Eschenbach, R Wender, et al.
Cancer
|
November 15, 1995
Randomized phase III study of 5-fluorouracil plus high dose folinic acid versus 5-fluorouracil plus folinic acid plus methyl-lomustine for patients with advanced colorectal cancer
D V Jones, R J Winn, B W Brown, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
February 1, 1996
Mutations of p53 in Barrett's esophagus and Barrett's cancer: a prospective study of ninety-eight cases
P M Schneider, A G Casson, B Levin, et al.
Journal of Medicinal Chemistry
|
October 14, 1994
L-735,524: the design of a potent and orally bioavailable HIV protease inhibitor
B D Dorsey, R B Levin, S L McDaniel, et al.
Trials
|
August 4, 2022
A randomized controlled trial of customized adherence enhancement (CAE-E): study protocol for a hybrid effectiveness-implementation project
Jennifer B Levin, Farren Briggs, Carol Blixen, et al.
Page
of 78
Search research articles
Search
Showing results (721-730 of 774) with videos related to
Sort By:
Page
of 78
Pediatrics
|
February 1, 1997
Improving care for minority children with asthma: professional education in public health clinics
D Evans, R Mellins, K Lobach, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 26, 1994
L-735,524: an orally bioavailable human immunodeficiency virus type 1 protease inhibitor
J P Vacca, B D Dorsey, W A Schleif, et al.
International Journal of Cancer
|
August 26, 1998
Familial aggregation of colorectal cancer in Egypt
A S Soliman, M L Bondy, B Levin, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 15, 1995
Preoperative infusional chemoradiation therapy for stage T3 rectal cancer
T A Rich, J M Skibber, J A Ajani, et al.
Bioorganic & Medicinal Chemistry
|
September 1, 1994
Synthesis, antiviral activity, and bioavailability studies of gamma-lactam derived HIV protease inhibitors
R W Hungate, J L Chen, K E Starbuck, et al.
CA: a Cancer Journal for Clinicians
|
October 2, 2001
American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. Also: update 2001--testing for early lung cancer detection
R A Smith, A C von Eschenbach, R Wender, et al.
Cancer
|
November 15, 1995
Randomized phase III study of 5-fluorouracil plus high dose folinic acid versus 5-fluorouracil plus folinic acid plus methyl-lomustine for patients with advanced colorectal cancer
D V Jones, R J Winn, B W Brown, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
February 1, 1996
Mutations of p53 in Barrett's esophagus and Barrett's cancer: a prospective study of ninety-eight cases
P M Schneider, A G Casson, B Levin, et al.
Journal of Medicinal Chemistry
|
October 14, 1994
L-735,524: the design of a potent and orally bioavailable HIV protease inhibitor
B D Dorsey, R B Levin, S L McDaniel, et al.
Trials
|
August 4, 2022
A randomized controlled trial of customized adherence enhancement (CAE-E): study protocol for a hybrid effectiveness-implementation project
Jennifer B Levin, Farren Briggs, Carol Blixen, et al.
Page
of 78